S- and G2-phase cell cycle arrests and apoptosis induced by ganciclovir in murine melanoma cells transduced with herpes simplex virus thymidine kinase

Experimental Cell Research
S J WeiW K Yang

Abstract

Mechanism of cell killing by transfer of Herpes simplex virus type-1 thymidine kinase (HSVtk) and subsequent ganciclovir (GCV) treatment was examined in B16F10 murine melanoma model. While parental B16F10 melanoma cells were resistant to GCV at 100 microM or higher, HSVtk-transduced B16F10 melanoma cell clones became susceptible to GCV with IC50 of 0.1 to 0.3 microM. By means of various parameters including characteristic morphological changes, in situ DNA end-labeling, DNA ladder pattern, flow cytometric detection of sub-G1 DNA content, and annexin V binding of inverted cell surface phosphatidylserine, apoptosis was shown to be associated with the cell killing of ganciclovir on HSVtk-transduced melanoma B16F10 cells. Kinetic analysis showed that the signs of apoptosis were observed not until 60 h of continued GCV treatment and preceded first by a rise in p53 protein level in 12 h and then by S-phase/G2-phase cell cycle arrest associated with corresponding increases in the level of cyclin B1 protein but no apparent change in protein level of Bax or Cdc2. These results suggest that apoptosis occurred as a result of ganciclovir-induced cell cycle arrests rather than direct chemical effect on HSVtk-transduced B16F10 melanoma cells.

References

Sep 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·B E HuberT A Krenitsky
Oct 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·E BorrelliR M Evans
Aug 1, 1986·Molecular and Cellular Biology·A D Miller, C Buttimore
Nov 21, 1995·Proceedings of the National Academy of Sciences of the United States of America·J FickM A Israel
Dec 23, 1994·Science·A Sancar
Dec 11, 1994·Nucleic Acids Research·M HerrmannJ R Kalden
May 10, 1994·Proceedings of the National Academy of Sciences of the United States of America·D BarbaF H Gage
Apr 2, 1993·Science·C P Selby, A Sancar
May 30, 1996·Nature·D E Birch

❮ Previous
Next ❯

Citations

Mar 21, 2009·Cancer Gene Therapy·J J O'KonekD S Shewach
Mar 5, 2002·Human Gene Therapy·Donna S ShewachWilliam B Parker
Jan 12, 2008·World Journal of Gastroenterology : WJG·Nima KhalighinejadAmir Momeni
May 29, 2012·Cancer Letters·Sónia DuarteValérie Pierrefite-Carle
May 6, 2008·Antiviral Research·N SolaroliA Karlsson
Sep 15, 2004·European Journal of Pharmacology·Anas El-Aneed
Oct 6, 2011·Journal of Experimental & Clinical Cancer Research : CR·Laetitia FinziRobert Malafosse
Jul 29, 2006·Cellular & Molecular Biology Letters·Marcin OkrójJacek Bigda
Feb 1, 2013·Journal of Liposome Research·Mark P WehuntVladimir Sidorov
Jan 3, 2012·International Journal of Pharmaceutics·Sónia DuarteMaria C Pedroso de Lima
Oct 24, 2014·The AAPS Journal·Jin ZhangMingnan Chen
May 18, 2001·Molecular Therapy : the Journal of the American Society of Gene Therapy·C RivasJ V Melo
Jun 27, 2002·Breast Cancer Research and Treatment·Lakshmi SivaramanBert W O'Malley
Mar 8, 2000·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·L MohrJ R Wands
Jan 22, 2003·Cancer Gene Therapy·Carlos ParadaSantiago Ramón y Cajal
Feb 21, 2006·World Journal of Gastroenterology : WJG·Andreas P Sutter, Henry Fechner

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.